{"id":"W2167655328","doi":"10.1038/cr.2014.37","title":"Biomarker-guided sequential targeted therapies to overcome therapy resistance in rapidly evolving highly aggressive mammary tumors","year":2014,"lang":"en","type":"article","venue":"Cell Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University","funders":"Cancer Prevention and Research Institute of Texas; University of Texas MD Anderson Cancer Center; Susan G. Komen; University of Pennsylvania; National Cancer Institute; National Institutes of Health","keywords":"Lapatinib; Trastuzumab; PTEN; PI3K/AKT/mTOR pathway; Cancer research; Biomarker; Biology; Targeted therapy; Breast cancer; Cancer; Medicine; Bioinformatics; Pharmacology; Signal transduction; Cell biology; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004777937,0.0003136403,0.0005982091,0.0005067308,0.0001793548,0.0007152488,0.0004049933,0.0003551947,0.001106227],"category_scores_gemma":[0.0004487447,0.0002025019,0.000242623,0.000352441,0.0001935052,0.0006567639,0.0003413852,0.0006942873,0.0002421737],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005287777,"about_ca_system_score_gemma":0.0004195405,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004985026,"about_ca_topic_score_gemma":0.001673502,"domain_scores_codex":[0.9998786,0.00001958301,0.000009696021,0.00003025377,0.00003323578,0.00002853673],"domain_scores_gemma":[0.9998933,0.00002430229,0.00003252108,0.00001338078,0.00001884033,0.00001765984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.002492131,0.000998258,0.01067577,0.0003841046,0.0001659321,0.0005026102,0.0001487668,0.009670464,0.49316,0.002494588,0.004784618,0.4745228],"study_design_scores_gemma":[0.001271171,0.01161519,0.0453989,0.0001549698,0.00096249,0.006940636,0.0004557511,0.09925576,0.7586471,0.006195544,0.06900591,0.00009640373],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9561147,0.02142844,0.01610099,0.001676438,0.0001995521,0.000210029,0.0002484214,0.0003805169,0.003640875],"genre_scores_gemma":[0.9823784,0.004986357,0.0103553,0.0002849627,0.0000637786,0.00007660581,0.0002494591,0.00004213463,0.001562937],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001106227,"threshold_uncertainty_score":0.003836632,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1014900660765387,"score_gpt":0.4059939835923612,"score_spread":0.3045039175158225,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}